January 18-20, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
Our understanding of the microbiome is advancing rapidly, and continues to productively move through the discovery phase, with numerous correlations being established between specific commensal microbes or microbiota compositions and a wide range of diseases that includes infections, inflammatory conditions, metabolic disease, autoimmunity and neurologic syndromes. The initial discovery of these potentially important correlations has led many laboratories around the world to probe the molecular mechanisms that form the causal link between specific commensal microbes and disease development, progression and resolution. Although there have been great advances, culturing many of the prevalent and metabolically active obligate anaerobic commensals remains a challenge. Exciting advances, however, are emerging from laboratories developing tools to genetically manipulate key commensal organisms, facilitating experimental studies that are identifying the small, bioactive molecules they produce, some of which have therapeutic potential. Studies of the impact of bacteriophage on the microbiota also suggest that they may have therapeutic potential. This Keystone conference will focus on recent advances that demonstrate, at the cellular and molecular level, the impact of the microbiota and its products on disease susceptibility/resistance, with an emphasis on microbial and host metabolism, inter-microbial interactions and the amelioration of diseases.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
for Short Talk Consideration: December 7, 2020
ePoster Abstract Submission: January 4, 2021
Financial Aid Application: January 4, 2021
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration
ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Speaking at this eSymposia
Emily P. Balskus
Harvard University, USA
Paul L. Bollyky
Stanford University, USA
Laurie E. Comstock
Brigham and Women's Hospital/Harvard Medical School, USA
Mohamed S. Donia
Princeton University, USA
Michael A. Fischbach
Stanford University, USA
Wendy S. Garrett
Harvard School of Public Health, USA
Andrew L. Goodman
Yale School of Medicine, USA
Jeffrey I. Gordon
Washington University School of Medicine, USA
Weill Cornell Medicine, USA
University College Cork, Ireland
Keio University School of Medicine, Japan
Lora V. Hooper
University of Texas Southwestern Medical Center, USA
Ivaylo I. Ivanov
Columbia University, USA
University of Chicago, USA
Denise M. Monack
Stanford University, USA
European Molecular Biology Laboratory, Germany
University of California, San Diego, USA
Boston Children's Hospital, USA
Cynthia L. Sears
Johns Hopkins University School of Medicine, USA
University of California, Berkeley, USA
Memorial Sloan Kettering Cancer Center, USA
Ludwig-Maximilians-Universität München, Germany
University of Aberdeen, Scotland
Massachusetts General Hospital, USA
Institut Gustave Roussy, France
Subscribe to receive updates to the program for this meeting.
Funding for this conference was made possible (in part) by Grant No. 1R13AI154725-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
Explore all cancer-related meetings on the Keystone Symposia website.